- Why You And Your Pooch Share Similar Reactions to Life
- How to Gauge Your Personal Risk For a Hernia
- Journalists Talk Medicaid Work Mandate in Georgia and Wage Garnishment Bill in Colorado
- How NYU Langone built 1 of the nation’s fastest-growing GI divisions
- BCBS study: Hospital AI billing tools may be driving up healthcare costs by billions
- The transition gap: How RCA is using recovery housing to prevent relapse
- CMS moves forward with 3rd round of Medicare drug negotiations
- Kroger pharmacies add Zepbound KwikPen
- Nurses navigate AI-generated health information at bedside
- Louisiana senator resumes push to repeal water fluoridation program
- HCA’s highest-earning executives in 2025
- CHS Alabama hospital CEO heads to Florida
- RWJBarnabas New Jersey hospital taps new COO
- Why some health system CEOs are opting out of cross-market expansion
- Stanford Health Care leader to advise agentic AI startup
- Piedmont, Encompass tap CEO for planned Georgia hospital
- Inside Virginia’s 1st ‘tri-accredited’ bariatric surgery center
- The red flags DSOs can’t afford to ignore
- 10 federal government, policy updates for dentists to know
- The highest-paid ophthalmologist in the 10 largest Northeastern cities
- Arizona cardiology group pays $4.75M to settle false claims allegations
- Why AI is keeping dental practice owners up at night
- OSF HealthCare uses text outreach after ED visits — and sees 33% engagement
- Medicare spending on ASCs jumps 16% in 1 year: MedPAC
- The uneven competition in physician markets
- ‘Dark Money’ Group Angles for Higher Medicare Advantage Payments
- Inside the erosion of independence in cardiology
- OIG green-lights ASC cataract supply discount proposal
- Children’s Hospital of Philadelphia anesthesiologist receives lifetime achievement award
- Oceans Behavioral Hospital debuts virtual outpatient program
- UF Health opens 24K-square-foot orthopedic surgical center
- Illinois health association to open $4M dental practice
- 30+ dental industry updates in California, Florida and Texas
- Heartland Dental expands in 4 states
- Crestwood Behavioral Health names program chief
- Dartmouth hospital launches social work department
- 5 DSOs making headlines
- Oceans behavioral health hospital taps CEO
- Amazon launches health AI agent on its website, expands free virtual care to 200M Prime members
- Pediatric dental, orthodontic practice building sold for $4.4M
- San Francisco secures $100M to expand behavioral health treatment to 3 sites
- Study Finds 'Forever Chemicals' on California Fruits and Vegetables
- Bad News for Multitaskers: Your Brain Can’t Really Do It
- OSF HealthCare uses digital therapeutics to create a digital path to care
- Former Tenet CFO joins Acadia Healthcare board
- About 3,000 Wayfair Dressers Recalled Over Child Tip-Over Risk
- Microsoft Unveils AI Health Tool That Can Read Your Medical Records
- FDA Town Hall: FDA’s Quality Management System Regulation (QMSR) – Medical Device Risk-Based Inspections
- FDA Town Hall: FDA’s Quality Management System Regulation (QMSR) – Medical Device Risk-Based Inspections
- The feds will overpay Medicare Advantage plans by $76B this year, MedPAC estimates
- FDA Launches New Adverse Event Look-Up Tool
- FDA Launches New Adverse Event Look-Up Tool
- FDA Issues Final Guidance on Medical Devices with Indications Associated with Weight Loss
- FDA Issues Final Guidance on Medical Devices with Indications Associated with Weight Loss
- The 510(k) Pathway in 2026: Navigating a Shifting Regulatory and Political Landscape for Medical Devices
- The 510(k) Pathway in 2026: Navigating a Shifting Regulatory and Political Landscape for Medical Devices
- Bayer found to have discredited pharma industry after Roche row
- Industry Voices—Fast answers, fragile data: the trust problem in AI-driven healthcare analytics
- Pfizer CEO Albert Bourla collects $27.6M in 2025 pay following Metsera, MFN deals
- GSK catches up to Pfizer, Moderna with FDA expansion for Arexvy
- Experts Weigh in on Digital Health Wearables for Neurological Health
- Ultra-Processed Foods Bad For Bone Health, Researchers Say
- AI-Generated Meal Plans For Dieting Teens Could Be Harmful, Study Warns
- Fertility Treatments Aren't Linked To Added Cancer Risk For Women, Study Concludes
- There's One Simple Way Cancer Patients Can Ward Off 'Chemo Brain,' Study Finds
- Younger Stroke Survivors Face Unique Mental Health Hurdles
- 'Manufacturing is access': How Gilead's early production moves set PrEP med Yeztugo up for success
- Medicare Advantage ‘Dark Money’ Group Attempts To Win Higher Payments for Insurance Companies
- Doctors Warn of a Deadly Complication From Measles Outbreaks
- Families Scramble To Pay Five-Figure Bills as Clock Ticks on Promised Preauthorization Reforms
- FDA scolds CDMO Simtra with warning letter over contamination fumbles
- FDA fires off another manufacturing-related CRL, this one to Hyloris
- Florida woman accused of operating illegal dental clinic out of home
- North Carolina updates mental health bed registry
- What the Health? From KFF Health News: RFK Jr.’s Very Bad Week
- Report on doctor's sexual abuse spurs promises of structural change at Columbia. Survivors say it isn't enough
- Fierce Pharma Asia—A trio of Lilly investments; Pfizer, Sciwind's GLP-1 nod; Astellas' MFN windfall
- Remarks at the Investor Advisory Committee Meeting
- Pediatric Allergy Specialist: Feed Babies Allergenic Foods Earlier, Not Later
- FDA Warns Novo Nordisk Broke Safety Reporting Rules
- Doctors Warn Patients to Research Cosmetic Surgery Providers Before Getting Work Done
- Adam’s Lib: Remarks at the Meeting of the SEC Investor Advisory Committee
- Remarks for the Investor Advisory Committee Meeting
- Gallup poll: One in three Americans cutting back on daily expenses to pay for healthcare
- AMA: Physicians' use of AI doubled from 2023 to 2026
- Study Suggests Epilepsy Drug Sulthiame May Help Treat Sleep Apnea
- At HIMSS26, Dr. Oz, CMS officials push agentic AI adoption. Are Medicare beneficiaries ready?
- Stryker Cyber Attack Being Reported as Iranian War Retaliation
- Stryker Cyber Attack Being Reported as Iranian War Retaliation
- After China outlay, Lilly plugs $126M into Japan manufacturing plant expansion
- Legend remains bullish on Carvykti growth despite threat from J&J’s Tecvayli
- FDA rolls out new streamlined adverse event monitoring system, eyes $120M in savings
- Eisai chooses 'Pokémon Sleep' app to battle bad sleep habits in awareness campaign
- Genetic Test May Predict Leukemia Relapse Risk
- Electrodes Partially Restore Movement, Sensation In Spinal Cord Patients
- Switching GLP-1 Medications Is Common, Can Help People Stick With Weight-Loss Treatment
- Millions Of Americans Making Financial Sacrifices To Afford Health Care, Survey Finds
- More Concussions Linked To Worse Brain Health Among Recent College Grads
- Years of Specialized Support Essential with Rare Heart Defects
- In latest compounding clash, Lilly flags high levels of 'impurity' in tirzepatide knockoffs with vitamin B12
- New Medicaid-focused doula provider Malama launches with $9.2M
- Republicans Fret Over RFK Jr.’s Anti-Vaccine Policies While MAHA Moms Stew
- As Lung Disease Threatens Workers, Lawmakers Seek Protections for Countertop Manufacturers
- Rare disease drug sales to surge past $400B by 2032 despite FDA volatility: Evaluate report
- Microsoft unveils Copilot Health as an AI health companion for consumers
- HIMSS26: HHS officials offer updates on interoperability efforts, information blocking enforcement
- Despite insurers' expense pains, Tenet Healthcare is securing healthy commercial rates through 2027
- Study Links State Taxes to COVID Lockdown Decisions
- Aetna to pay $117.7M to settle Medicare Advantage upcoding allegations: DOJ
- UPDATED: Stryker hit by international cyberattack linked to pro-Iran group
- AHA: Hospitals' total expenses rose by 7.5% in 2025
- AstraZeneca recruits Joshua Jackson, Philadelphia Flyers' Gritty to cancer screening push
- As Lilly flourishes in Q4, peer projections signal looming sector slowdown in 2026
- FDA May Allow Some Flavored Vapes Aimed at Adults
- Dark Sweet Cherries May Help Slow Aggressive Breast Cancer, Mouse Study Suggests
- FDA Approves Leucovorin for Rare Brain Disorder, Not Autism
- Joint Economic Committee report: Medicare Advantage overpayments drive up Part B premiums
- Veeva shells out $100M for Ostro and its AI chat tool for pharma brand engagement
- Lilly beefs up oral GLP-1 capacity with $3B manufacturing pledge in China
- UCB's Bimzelx continues winning streak with victory over AbbVie's Skyrizi
- Lowering Parents' Stress Can Reduce Risk Of Childhood Obesity
- Multilingualism Might Not Aid Brain Aging, Researcher Argues
- 15-Year Study Shows Sharp Rise in Depression Among U.S. College Students
- Repealing Motorcycle Helmet Laws Leads to More Severe Crashes, Millions in Added Treatment Costs
- Why Childhood Cavities May Predict Adult Heart Disease
- Physical Therapy Costs Vary Widely In U.S., Study Finds
- J&J's Joaquin Duato joins $30M CEO pay club with 30% compensation boost for 2025
- Cosmetic Surgery Investigation Prompts Warnings for Patients, and a Push for Tighter Safety Standards
- Primary Care Is in Trouble. So Doctors Band Together To Boost Their Market Power.
- Skyhawk taps Teva alum to steer commercial path, while Santhera names new CCO to grow DMD sales
- Driving the news at HIMSS26: Verily, Samsung ink collaboration; Meditech's latest AI solutions
- Remarks at the Institute of International Bankers 2026 Annual Washington Conference
- Fostering Regulatory Harmony Between the SEC and CFTC
- Here's where hospital markets are the most concentrated
- A look at how CVS is leaning on 'agentic twins' in developing consumer tech
- Patent expirations push biopharma industry toward a tougher 2026
- Sandoz to set up standalone biosimilars unit as it eyes upcoming 'golden decade' of patent losses
- AbbVie's Robert Michael earns hefty pay bump to $32.5M in 2nd year as CEO
- NYU Stern report calls for private equity reforms to safeguard quality of care
- Remarks at the International Bar Association’s 24th Annual International Conference on Private Investment Funds
- Raw Oysters and Clams Recalled After Norovirus-Like Illness Outbreak in Washington
- Mammograms May Also Reveal Hidden Heart Disease Risk, Study Finds
- Chile Becomes First Country in the Americas To Eliminate Leprosy
- Going Abroad? CDC Warns Travelers About Polio Risk in Several Countries
- The Fierce Healthcare team on the Fierce 15 of 2026
- Centene's stock falls as CEO London outlines ongoing ACA headwinds
- AI-fueled misdiagnoses, rural care barriers are 2026's top patient safety threats: ECRI
- Patients want price transparency, e-commerce experience from pharma DTP platforms: survey
- Carrum Health teams up with Virta Health on a comprehensive weight loss solution
- Nearly Half of U.S. Kids Lack Adequate Sleep, Survey Shows
The Michigan Department of Agriculture and Rural Development (MDARD) and MDHHS are warning against online purchases of unregistered pesticides containing organophosphate dichlorvos (DDVP), specifically “Sniper” and “Nopest”. These insecticides destroy nervous system functioning, just as military nerve gasses do. Neither Michigan department explains the meaning of registration in this joint press release, but I think they are referring to Agency for Toxic Substances and Disease Registry (ATSDR) registration:
https://www.michigan.gov/mdhhs/inside-mdhhs/newsroom/2026/02/09/ddvp-warning
https://www.michigan.gov/mdard/plant-pest/pesticides
MDHHS and MDARD urge residents to use caution when buying and using pesticides
By Lynn Sutfin - February 09, 2026Recent poisonings due to pesticides containing dichlorvos prompt warning
LANSING, Mich. – The Michigan Department of Health and Human Services (MDHHS) and Michigan Department of Agriculture and Rural Development (MDARD) are warning residents to avoid purchasing unregistered pesticides containing dichlorvos (DDVP), including brand names “Sniper” and “Nopest.”
Despite their potentially harmful health effects, “Sniper” and “Nopest” remain available for purchase via online marketplaces, where they are marketed as insecticides for home use. These and other pesticides that contain highly concentrated DDVP are responsible for recent poisonings in Michigan. Consumers should be aware that not all pesticides purchased online are registered by the U.S. Environmental Protection Agency (EPA) or are safe to use at home. Neither “Sniper” or “Nopest” are registered by EPA.
“These recent cases are a serious reminder that unregistered or illegal pesticide products can pose significant risks to public health,” said MDARD Director Tim Boring. “MDARD urges residents to take simple steps, such as checking for an EPA registration number and following label directions, to protect themselves, their families and the environment.”
Pesticides are any substance used to kill or repel pests to reduce the damage they cause. They include disinfectants, fungicides, insecticides, herbicides and animal repellants.
If you become sick after being exposed to pesticides, contact Poison Control at 800-222-1222 or call your health care provider. If you become severely ill or have a hard time breathing, call 911 or go to the emergency room.
“We urge Michigan residents to use precaution when using pesticides to prevent harm to themselves, their family or pets,” said Dr. Natasha Bagdasarian, chief medical executive. “If you suspect pesticide poisoning, move to fresh air, remove any contaminated clothing, wash skin with soap and water, and seek medical attention.”
Pesticide poisoning symptoms include:
- Eye, nose and/or throat irritation.
- Headache.
- Nausea.
- Seizures.
- Shortness of breath.
- Skin irritation.
- Coma.
- Death.
Risk of pesticide poisoning depends on the following:
- Toxicity.
- Length of exposure.
- Amount of pesticide.
- Type of exposure, such as breathing it in, getting it in the eyes or on the skin, or eating or drinking it.
To avoid serious injury or illness when using pesticides:
- Purchase pesticides with an EPA Registration Number (“EPA Reg. No.”) and an EPA Establishment Number (“EPA Est. No.”) on the label. These are tested to make sure they do not cause major risks to human health or the environment when used as directed.
- Read and follow the label. Following label directions is the only safe way to use a pesticide.
- Wear required protective clothing and equipment such as gloves, eye protection or masks.
- Do not spray pesticides outdoors when it is windy.
- Wipe, rather than spray, disinfectant products indoors.
- Wash hands and clothing after using pesticides.
- Store pesticides in a safe place away from children and pets.
Residents who discover they have unregistered pesticides in their possession should immediately dispose of these products using the following steps:
- Wear protective clothing, gloves and a face mask, and double bag the bottle or container in heavy plastic.
- Add sand, dirt or kitty litter to the bag, if possible, especially if the bottle is leaking.
- Contact the local waste management company to find out where to safely dispose of the container.
- Do not let children or pets near the pesticide.
- Do not pour the pesticide down the drain.
Pesticide poisoning in Michigan
Since 2001, there have been three confirmed unintentional pesticide-related deaths. While deaths from pesticides are rare, more than 2,700 total confirmed pesticide illnesses or injuries were reported in the past decade.
For more information about pesticides, visit:
MDHHS pesticide illness webpage
MDARD pesticides webpage
Pesticides are also a health issue at the national level, in the USDA "farm bill":
https://thehill.com/policy/energy-environment/5737733-farm-bill-pesticides-maha/
In farm bill, GOP takes another swing at pesticide protections loathed by MAHA
By Rachel Frazin - February 13, 2026Republicans are using the farm bill to take another swing at passing legislation to protect pesticides, something sure to anger their allies in the “Make America Healthy Again” (MAHA) movement.
A House Republican iteration of the farm bill released on Friday includes a provision that prevents states and courts from penalizing pesticide makers for failing to include warnings on their label about health effects that go beyond those formally recognized by the Environmental Protection Agency (EPA).
Proponents of such measures say they prevent companies from having to comply with a hodgepodge of rules that could differ from place to place.
However, opponents of such language argue that it could be used to tamp down on failure-to-warn lawsuits that seek to hold pesticide companies accountable for not disclosing alleged harms of their products.
Similar language was ultimately removed from an EPA appropriations package earlier this year amid pushback from Democrats and MAHA-aligned Republicans.
The MAHA movement has been spearheaded by Health and Human Services Secretary Robert F. Kennedy Jr. Its members are largely skeptical of big business, including Big Pharma, Big Ag and Big Chemical — breaking with other Republicans who are often big business allies.
While the measure applies to pesticides broadly, the issue is often talked about in terms of glyphosate, which has been a key ingredient in the weedkiller Roundup.
While the EPA says there’s “insufficient evidence to conclude that glyphosate plays a role in any human diseases,” multiple lawsuits have claimed otherwise — and have cost Bayer billions of dollars.
The question of whether such lawsuits are preempted under federal law will be reviewed by the Supreme Court this year.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.














